Full Text View
Tabular View
No Study Results Posted
Related Studies
Samarium Sm 153 Lexidronam Pentasodium With or Without Vaccine Therapy in Treating Patients With Prostate Cancer and Bone Metastases
This study is currently recruiting participants.
Study NCT00450619   Information provided by National Cancer Institute (NCI)
First Received: March 20, 2007   Last Updated: July 8, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Metastatic Cancer
Pain
Prostate Cancer
Additional conditions recognized in this trial
Neoplasm Metastasis
Prostatic Neoplasms
More general conditions related to this trial
Genital Diseases, Male
Genital Neoplasms, Male
Neoplasms
Neoplasms by Site
Neoplastic Processes
Pathologic Processes
Prostatic Diseases
Urogenital Neoplasms
Interventions listed in this trial
recombinant fowlpox-TRICOM vaccine
recombinant vaccinia-TRICOM vaccine
sargramostim
Additional drug interventions recognized in this trial
Samarium ethylenediaminetetramethylenephosphonate
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Central Nervous System Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services